02197 三葉草生物－Ｂ
按盘价 
0.265 -0.005 (-1.852%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -4.077% | -48.841% | -184.177% | -132.907% | -26.090% |
| 股东资金回报率 (%) | N/A | -889.965% | -5089.784% | N/A | 71.633% |
| 资本运用回报率 (%) | N/A | -131.434% | -188.153% | -81.451% | -30.608% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 61.753% | N/A | N/A | N/A | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -166.371% | N/A | N/A | N/A | N/A |
| 税前边际利润率 (%) | -352.921% | N/A | N/A | N/A | N/A |
| 纯利率 (%) | -352.921% | N/A | N/A | N/A | N/A |
變現能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 0.834 X | 1.552 X | 2.363 X | 15.711 X | 5.979 X |
| 速动比率 (X) | 0.528 X | 0.709 X | 2.005 X | 14.948 X | 5.965 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 134.873% | 114.232% | 77.194% | 182.755% | 136.421% |
| 总债项 / 总资产比率 (%) | 15.915% | 7.548% | 1.271% | 1.879% | 6.688% |
| 净债项 / 总资产比率 (%) | -19.102% | -26.691% | -50.498% | -41.588% | -73.162% |
| 总债项 / 股东资金比率 (%) | N/A | N/A | 5.571% | N/A | N/A |
| 长期债项 / 股东资金比率 (%) | N/A | N/A | 3.809% | N/A | N/A |
| 净债项 / 股东资金比率 (%) | N/A | N/A | -221.421% | N/A | N/A |
| 净现金 / (债项) ($) | 4.01亿 | 12.53亿 | 26.99亿 | 4.94亿 | 1.36亿 |
| 每股净现金 / (债项) ($) | 0.310 | 0.969 | 2.331 | -- | -- |
| 总债项 / 资本运用比率 (%) | N/A | 18.996% | 2.124% | 1.991% | 7.847% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 37454.412日 | -- | -- | -- | -- |
| 应收贸易帐周转率日数 (日) | 224.142日 | N/A | N/A | N/A | N/A |
| 应付贸易帐周转率日数 (日) | 5136.281日 | N/A | N/A | N/A | N/A |
| 备注： | 实时报价更新时间为29/07/2024 17:24 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -138,539,000 |
| 增长率 | -94.350% |
| 每股盈利/(亏损) | RMB -0.110 |
| 每股账面资产净值 (¥) | RMB -0.565 |